Journal of Biological Chemistry · 2020 · 14 citations · 38 references
Life SciencesOncologyPharmacologyDna RepairEnzymologyMolecular OncologyDna DamageDna Damage SignalingDna Double-strand Break RepairDna Repair DefectsDouble-strand Break RepairEnzyme InhibitionDna Damage Repair PathwaysDna Damage Response InhibitorsDna Damage Response TargetingDna Repair Pathway DefectsDna Repair PathwaysEnzymatic Activity ScreeningInhibitor ScreeningTumor Suppression Mechanisms
Moreover, hydrolysis of DNA damage-induced ADP-ribosylation was clearly inhibited when cells were pretreated with AI26, leading to defects in DNA damage repair. In addition, tumor cells with DNA damage repair defects were hypersensitive to AI26 treatment, as well as combinations of AI26 and other DNA-damaging agents such as camptothecin and doxorubicin. Collectively, these results reveal not only a chemical probe to study ARH3-mediated DNA damage repair but also a chemotherapeutic strategy for tumor suppression.
38
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature · 2005 · 6.7K citations
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Helen E. Bryant, Niklas Schultz, Huw D. Thomas et al. · Nature · 2005 · 5.2K citations
Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1
Marie-France Langelier, Jamie L. Planck, Swati Roy et al. · Science · 2012 · 681 citations